Clinical Trial Update: A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease [Phase 3]

View source ↗

Summary

This document reports on a Phase 3 randomized, placebo-controlled trial of rasagiline in Parkinson's disease, with results suggesting potential slowing of disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-06-21